View in EDS

Impact of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors on Post-liver Transplant New-onset Major Adverse Cardiovascular Events, Graft Failure, Renal Outcome, and Mortality.

Saved in:
Bibliographic Details
Title: Impact of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors on Post-liver Transplant New-onset Major Adverse Cardiovascular Events, Graft Failure, Renal Outcome, and Mortality.
Authors: Kosako Yost KC; Department of Internal Medicine, University of Arizona College of Medicine, Phoenix, AZ.; Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ., Ghai MB; Department of Internal Medicine, University of Arizona College of Medicine, Phoenix, AZ.; Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ., Aboona M; Department of Internal Medicine, University of Arizona College of Medicine, Phoenix, AZ.; Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ., Ali Q; Department of Internal Medicine, University of Arizona College of Medicine, Phoenix, AZ.; Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ., Rangan P; Department of Internal Medicine, University of Arizona College of Medicine, Phoenix, AZ.; Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine, Phoenix, AZ., Gomez P; Department of Internal Medicine, University of Arizona College of Medicine, Phoenix, AZ.; Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ., Nathan R; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ., Wong M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ., Wijarnpreecha K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ., Nevah Rubin MI; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ., Fallon M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ., Han MAT; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ.
Source: Transplantation direct [Transplant Direct] 2026 May 15; Vol. 12 (6), pp. e1935. Date of Electronic Publication: 2026 May 15 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 101651609 Publication Model: eCollection Cited Medium: Print ISSN: 2373-8731 (Print) Linking ISSN: 23738731 NLM ISO Abbreviation: Transplant Direct Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2373-8731
DOI:10.1097/TXD.0000000000001935